Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B342- Coronavirus infection, unspecified
Conditions
Interventions
Intervention1: AZADVIR Drops : Herbal steam inhaler: Two drops in steam inhaler
Twice daily
Morning and Evening
Duration : Day 0 to Day 7
Control Intervention1: NIL: NIL
Sponsors
HAOMA WELLNESS CENTER
Eligibility
Inclusion criteria
Inclusion criteria: 1. Male or non-pregnant female adult with or without comorbidities between the agre group of 18-85 years of age at time of enrollment 2. Has laboratory-confirmed positive COVID-19 infection as determined by RT-PCR or other commercial or public health assay in any specimen, an RT-PCR (Nasopharynx, Throat, and Blood) test shall be repeated to assess eligibility 3. Subject (or legally authorized representative) provides written informed consent prior to initiation of any study procedures 4. Health care workers who visited to COVID patients
Exclusion criteria
Exclusion criteria: 1. Testing positive for HIV, HbsAg, HCV infection, VDRL. 2. Females who are currently pregnant or breastfeeding. 3. Allergy or other contraindication to one of the investigational products. 4. Has received Eflornithine within the last 10 days. 5. Has received anti-viral, anti-malarial or anti-bacterial within the last 14 days. 6. Alanine Aminotransferase (ALT) or aspartate aminotransferase (AST) > 5 X upper limit of normal (ULN). 7. QTc interval >= 500ms. 8. Recent Myocardial Infarction (within last 6 months). 9. Known case of (K/C/O) Congestive heart failure. 10. K/C/O Chronic Kidney Disease. 11. K/C/O active Tuberculosis. 12. History of drug or alcohol dependence in the past 6 months. 13. In the opinion of the clinical team, progression to death is imminent and inevitable within the next 24 hours, irrespective of the provision of treatments. 14. Anticipated transfer to another hospital which is not a study site within 72 hours. 15. K/C/O of epilepsy or CNS disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy AZADVIR (Herbal steamInhaler) supplement in COVID-19 patients Expecting 5 to 7 days RT PCR COVID negative testTimepoint: Day 0 to Day 10 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ To assess the organoleptic properties of AZADVIR (Herbal steamInhaler) through a feedback questionnaireTimepoint: Day 0, Day 5 and Day 10 | — |
Countries
India
Contacts
Public ContactKavya Kannoth Shaji
HAOMA WELLNESS CENTER
Outcome results
None listed